Winnersrationale

A well-known name on the street, the T. Rowe Price Funds SICAV – Global Focused Growth Equity Fund has enjoyed an impeccable track record of nearly two decades and throughout multiple market cycles.

Bottom-up fundamental analysis powers the fund’s stock selection process and has long been its major source of alpha over the past years. The fund strategy has a tilt to growth investing — broadly defined so as to identify companies with improving fundamentals and growth prospects over a time horizon of 12 to 24 months.

The fund allows for the flexibility to add in contrarian perspectives and embraces some extent of market uncertainties. That means, for instance, in the current environment where cyclicals are outperforming, it benefits from its allocation to cyclical sectors such as financials. The approach enables the fund to go beyond traditional growth names for companies that can generate long-term sustainable growth. It is this unique approach that distinguishes the fund from many of its global equity peers.

Notable calls in 2021 that contributed to the fund’s outperformance include the bullish stance taken on Charles Schwab — the company’s earnings power was expected to receive a significant tailwind from the acquisition of TD Ameritrade in October 2020. The stock has consistently been generating alpha for the fund throughout the first two quarters of 2021.

The fund’s proven track record has won it a five-star rating by Morningstar. As of 31 August 2021, the fund had delivered a one-year after-fee total return of 31.29%, beating the MSCI world benchmark by 2.64%. Its calendar year performance in 2020 was 49.83%, versus the benchmark return of 16.25%. The fund integrates ESG factors as part of its investment process alongside other factors such as financial, macroeconomic and valuation.

T. Rowe Price has been named Asian Private Banker’s Best Fund Provider – Global Equity for 2022.